Gonzalez Jeffrey, Ocejo Stephanie, Iribarren Mercy, Abreu Alvaro, Bahmad Hisham F, Poppiti Robert
Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
The Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Cancers (Basel). 2024 Dec 7;16(23):4101. doi: 10.3390/cancers16234101.
Desmoplastic small round cell tumors (DSRCTs) of the gastrointestinal (GI) tract are a rare and highly aggressive variant of soft tissue sarcomas, predominantly affecting the abdominal region. These tumors are believed to originate from multipotent mesenchymal stem cells or primitive progenitor cells. They are composed of small round tumor cells associated with prominent stromal desmoplasia, polyphenotypic differentiation, and gene fusion. Diagnostically, DSRCTs present a significant challenge due to their histological resemblance to other small round cell tumors, such as Ewing sarcoma and rhabdomyosarcoma, necessitating the use of ancillary tests, including immunopanels and molecular analysis, to reach a definitive diagnosis. Immunohistochemical staining, including markers like cytokeratin, vimentin, desmin, and WT1, has proven valuable in differentiating DSRCTs from their mimickers. The prognosis of these tumors is highly dependent on factors such as tumor location and stage at diagnosis, and given their aggressive nature, a multidisciplinary approach may be required that combines surgical resection, chemotherapy, and radiation therapy, among other options. In this review, we provide a synopsis of the pathophysiology of DSRCTs and the latest diagnostic advancements, including the utility of molecular profiling and novel biomarkers.
胃肠道促结缔组织增生性小圆细胞肿瘤(DSRCT)是软组织肉瘤中一种罕见且侵袭性很强的亚型,主要累及腹部区域。这些肿瘤被认为起源于多能间充质干细胞或原始祖细胞。它们由与显著的间质促结缔组织增生、多表型分化和基因融合相关的小圆肿瘤细胞组成。在诊断方面,DSRCT因其组织学表现与其他小圆细胞肿瘤(如尤因肉瘤和横纹肌肉瘤)相似而极具挑战性,因此需要使用辅助检查,包括免疫组化面板和分子分析,以做出明确诊断。免疫组织化学染色,包括细胞角蛋白、波形蛋白、结蛋白和WT1等标志物,已被证明在鉴别DSRCT与其相似肿瘤方面很有价值。这些肿瘤的预后高度依赖于肿瘤位置和诊断时的分期等因素,鉴于其侵袭性,可能需要采取多学科方法,包括手术切除、化疗和放疗等多种选择。在本综述中,我们概述了DSRCT的病理生理学以及最新的诊断进展,包括分子谱分析和新型生物标志物的应用。